SWP
IMGN

Stratos Wealth Partners’s Immunogen Inc IMGN Stock Holding History

Stratos Wealth Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-472
Closed -$4K – 2639
2018
Q3 		$4K Buy
+472
New +$4.54K ﹤0.01% 2564
2018
Q2 		– Sell
-1,105
Closed -$12K – 2724
2018
Q1 		$12K Sell
1,105
-449
-29% -$4.43K ﹤0.01% 2248
2017
Q4 		$10K Buy
+1,554
New +$9.58K ﹤0.01% 2178

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Stratos Wealth Partners's IMGN Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Immunogen Inc (IMGN) in Q4 2018, closing a stake of 472 shares — an estimated $4K sold.

Stratos Wealth Partners first reported a position in IMGN in Q4 2017 and held it in 3 quarters. The position peaked at $12K in Q1 2018. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Immunogen Inc position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 472 Immunogen Inc shares in Q4 2018, an estimated $4K.
  • Stratos Wealth Partners first reported a position in Immunogen Inc in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Immunogen Inc position peaked at $12K in Q1 2018.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.